Looking for CAN to detect heart failure in type 2 diabetes
Aims: To study the association between cardiovascular autonomic neuropathy (CAN) and markers of heart failure (HF) in people with type 2 diabetes (T2D).
Methods: Two hundred participants with T2D were recruited in the Cardiovascular Autonomic Neuropathy for risk stratification in type 2 diabetes- CANCAN study. Manifest CAN was defined by the presence of two or more abnormal cardiovascular autonomic reflex test results using the Vagus device and age-based normative values. HF was defined by NT-proBNP levels >125pg/mL while symptomatic HF was defined by New York Heart Association (NYHA) classification score ≥II.
An adapted version of the WATCH-DM risk score was used to estimate the 5-year risk of incident HF hospitalization of the enrolled patients. Possible association between measures of CAN and HF were assessed.
Results: Among 134 individuals with valid CAN assessment, 40% had CAN. A higher proportion of CAN individuals had elevated NT-proBNP (51.9%) compared to those without CAN (23.2%). In the fully adjusted model, CAN was associated with 6.2 times higher odds (95% CI: 2.1; 20.8) of elevated NT-proBNP levels compared to individuals without CAN. Moreover, the association between CAN and elevated NTproBNP was similar in participants with very-low-to-moderate risk in the WATCH-DM score (OR=6.1) and those with high-to-very-high risk (OR=6.3). The association between CAN and elevated NT-proBNP was also present in asymptomatic individuals for HF (OR=4.3), and appeared stronger in symptomatic HF individuals (OR=16.4)
Conclusions: CAN is associated with indicators of HF, such as elevated NT-proBNP levels, NYHA scores, and WATCH-DM scores in patients with T2D. CAN may supplement established biomarkers to identify individuals with earlier HF stages.
Comments. CAN represents a high-risk for more severe cardiovascular complications and increased mortality (Chowdhury M et al BMJ Open Diabetes Res Care. 2021;9(2):e002480). In fact, CAN causes cardiac and arterial remodelling, resulting in structural and functional alterations of the heart and promoting the progression of HF before clinical symptoms appear. In this cross-sectional study, despite the absence of echocardiography, the gold standard for assessing HF, the authors described the potential role of CAN in identifying high-risk individuals for HF. Moreover, the association between CAN and elevated NT-proBNP was present in asymptomatic individuals for HF and similar among those with both high and low-to-moderate WATCH-DM categories. This suggests that CAN may provide additional information beyond WATCH-DM risk score and symptoms of HF defined by NYHA score. Longitudinal evaluation, with follow-up data on HF hospitalizations, will corroborate these findings and could help in understanding the role of SGLT2is and GLP1RAs in both complications.
Marika Menduni
Reference. Schaarup JR, Bjerg L, Hansen CS, Witte DR, Thomsen HH, Fleischer J, Pop-Busui R, Andersen ST. Cardiovascular Autonomic Neuropathy and Indices of Heart Failure in Type 2 Diabetes: The CANCAN Study. Diabetes Obes Metab. 2026 Oct;28(10):9356-9366. doi: 10.1111/dom.71100. Epub 2026 Jul 28. PMID: 42521606; PMCID: PMC13538821.